Featured Research

from universities, journals, and other organizations

WHO Sets Up Network To Combat Corruption In Medicines Procurement

Date:
October 31, 2006
Source:
World Health Organization
Summary:
Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.

Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.

The World Health Organization (WHO) recently launched a new initiative to assist governments to combat corruption by promoting greater transparency in medicines regulation and procurement. WHO is establishing a group of anti-corruption and medicines experts from international institutions and countries to promote greater transparency.

Before reaching the patients who need them, medicines change hands several times in the complex production and distribution chain, providing ample opportunity for corruption. A recent report by Transparency International* revealed that in one country, the value of two out of three medicines supplied through procurement was lost to corruption and fraud in hospitals.

"This is an aberration when you think that poor populations struggle with the double bind of a high burden of disease and low access to medical products," said Dr Howard Zucker, WHO Assistant Director-General for Health Technology and Pharmaceuticals. "Countries need to deal with this problem and ensure that the precious resources devoted to health are being well spent."

Apart from the loss of resources and the danger posed to patients’ lives, corrupt practices also allow the entry into the medicines chain of counterfeit and substandard products, further endangering the health of communities.

Corruption occurs at different stages of the chain and may take on different forms:

  • Bribery of government officials to register medicines without the required information;
  • Government officials may deliberately slow down registration procedures to solicit payment from suppliers;
  • Favouritism rather than professional merit in selecting members of a medicines registration committee or in recruiting regulatory staff;
  • Thefts and embezzlement in the distribution chain, including in health care facilities.

To combat the problem, WHO plans to strengthen regulatory authorities and procurement practices by:

  • Stimulating legislative reform that will establish laws against corruption and commensurate enforcement and punitive measures;
  • Promoting standardized systems of checks and balances to limit or prevent abuse by making publicly available the criteria, structures and procedures applied to select regulatory and procurement staff and medical products;
  • Encouraging ethical practices through behaviour change activities and staff training.

The first step of the process will be to create a group of independent experts and advocates. Second, the organization will compile a data base of best practices and successful experiences already tried and tested in countries to promote good governance in the public pharmaceutical sector.

“Corruption is a worldwide problem, rife in high- and low-income countries alike, and no country should feel embarrassed to talk about it,” said Dr Hans Hogerzeil, WHO Director of Medicines Policy and Standards. “But low income countries are the most vulnerable, and they are the ones we will initially support in promoting more transparent, money-saving tactics.”

A two-day meeting to set out strategies and set up the new initiative is taking place at WHO Headquarters, Geneva, on 30-31 October 2006.


Story Source:

The above story is based on materials provided by World Health Organization. Note: Materials may be edited for content and length.


Cite This Page:

World Health Organization. "WHO Sets Up Network To Combat Corruption In Medicines Procurement." ScienceDaily. ScienceDaily, 31 October 2006. <www.sciencedaily.com/releases/2006/10/061030122931.htm>.
World Health Organization. (2006, October 31). WHO Sets Up Network To Combat Corruption In Medicines Procurement. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2006/10/061030122931.htm
World Health Organization. "WHO Sets Up Network To Combat Corruption In Medicines Procurement." ScienceDaily. www.sciencedaily.com/releases/2006/10/061030122931.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins